肝细胞癌在计算机断层扫描与PET上的联合Hounsfield单位作为活体供肝移植术后早期复发的无创预测指标:至复发时间生存分析
该回顾性研究纳入131例活体供肝移植前可测量存活肝细胞癌且接受增强CT与PET评估的患者,随访至少6年。多因素分析显示动脉期肿瘤强化Hounsfield单位与PET均为无复发生存的独立预后因素;CT动脉期肿瘤强化Hounsfield单位截断值59.2(AUC 0.88)和PET阳性(AUC 0.89)均提示早期复发风险增高;两者联合(Hounsfield单位<59.2且PET阳性)的AUC达0.96。
要点
- CT动脉期肿瘤强化Hounsfield单位截断值59.2与PET阳性均为早期复发的独立预测指标。
- 动脉期Hounsfield单位<59.2且PET阳性联合诊断早期复发的AUC为0.96。
- 动脉期肿瘤强化Hounsfield单位与PET联合可作为活体供肝移植术后早期复发的影像标志物。
核心结论
- CT增强动脉期肿瘤强化Hounsfield单位较低可有效预测活体供肝移植术后肝细胞癌早期复发;CT与PET联合可能作为移植后早期复发的影像标志物。
研究设计与样本
- 回顾性研究,618例活体供肝移植肝细胞癌患者中纳入131例术前增强CT和PET可测量存活肝细胞癌者,最短随访6年,采用Cox回归、时间依赖ROC曲线和AUC评估CT与PET的预测效能。
关键影像表现/征象
- 术前增强CT动脉期肿瘤强化Hounsfield单位较低(截断值59.2)与PET阳性均与早期复发风险增高相关。
- 动脉期肿瘤强化Hounsfield单位<59.2且PET阳性的复合指标诊断早期复发的AUC为0.96。
诊断标准与关键数值
- 0.5年时间依赖ROC分析中,CT动脉期肿瘤强化Hounsfield单位截断值59.2预测早期复发的AUC为0.88。
- PET阳性预测早期复发的AUC为0.89。
- 动脉期肿瘤强化Hounsfield单位<59.2且PET阳性联合诊断早期复发的AUC为0.96。
临床应用与阅片要点
- 阅片时可关注增强CT动脉期肿瘤强化Hounsfield单位,并结合PET结果评估活体供肝移植术后早期复发风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Liver transplantation is an effective treatment for preventing hepatocellular carcinoma (HCC) recurrence. This retrospective study aimed to quantitatively evaluate the attenuation in Hounsfield units (HU) on contrast-enhanced computed tomography (CECT) as a prognostic factor for hepatocellular carcinoma (HCC) following liver transplantation as a treatment. Our goal is to optimize its predictive ability for early tumor recurrence and compare it with the other imaging modality-positron emission tomography (PET).
METHODS: In 618 cases of LDLT for HCC, only 131 patients with measurable viable HCC on preoperative CECT and preoperative positron emission tomography (PET) evaluations were included, with a minimum follow-up period of 6 years. Cox regression models were developed to identify predictors of postoperative recurrence. Performance metrics for both CT and PET were assessed. The correlation between these two imaging modalities was also evaluated. Survival analyses were conducted using time-dependent receiver operating characteristic (ROC) curve analysis and area under the curve (AUC) to assess accuracy and determine optimized cut-off points.
RESULTS: Univariate and multivariate analyses revealed that both arterial-phase preoperative tumor attenuation (HU) and PET were independent prognostic factors for recurrence-free survival. Both lower arterial tumor enhancement (Cut-off value = 59.2, AUC 0.88) on CT and PET positive (AUC 0.89) increased risk of early tumor recurrence 0.5-year time-dependent ROC. Composites with HU < 59.2 and a positive PET result exhibited significantly higher diagnostic accuracy in detecting early tumor recurrence (AUC = 0.96).
CONCLUSION: Relatively low arterial tumor enhancement values on CECT effectively predict early HCC recurrence after LDLT. The integration of CT and PET imaging may serve as imaging markers of early tumor recurrence in HCC patients after LDLT.
引用
- Kan NN, Yu CY, Cheng YF, et al. Combined Hounsfield units of hepatocellular carcinoma on computed tomography and PET as a noninvasive predictor of early recurrence after living donor liver transplantation: Time-to-recurrence survival analysis. Eur J Radiol. 2024. PMID: 38875747. doi:10.1016/j.ejrad.2024.111551
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。